The population cohort for this prospective observational study included 25 ONHD patients (12 visible and 13 buried ONHD; 14 females and 11 males; mean age, 32.86; SD ± 22.50) and 24 ODE patients. Two patients with ODE who also showed ONHD on ultrasound examination were excluded, so that data of 22 patients with ODE were analyzed (21 had idiopathic intracranial hypertension and 1 had cavernous sinus thrombosis; 16 females and 6 males; mean age, 33.82; SD ± 13.93). We also studied 25 healthy volunteers (14 females and 11 males; mean age, 35.94; SD ± 14.54).
The ONHD and ODE participants were recruited prospectively. Healthy participants were recruited from the University of Leicester and University Hospitals Leicester National Health Service (UHL NHS) staff, their relatives, friends, and partners of clinic patients.
Complete clinical examination was performed on all subjects, including best-corrected visual acuity, IOP measurements, visual field testing (24-2 pattern, Humphrey Field Analyzer; Carl Zeiss Meditec AG, Jena, Germany), and refraction. Additional examinations, including computer tomography and/or magnetic resonance imaging, and lumbar puncture, were performed if necessary to confirm the diagnosis; eye ultrasound and tests for autofluorescence of the optic nerve were done in all ONHD patients.
Patients with ONHD had at least two of five findings, previously used in other publications investigating ONHD,
7 including visible ONHD, autofluorescence, calcification on ocular ultrasound, normal cerebrospinal fluid pressure, and constant disc elevation.
The ODE patients were examined during the acute stage of the disc swelling. Magnetic resonance imaging was performed in all patients, and indicated signs of cavernous sinus thrombosis in one patient and was normal in the remaining participants. All participants from the ODE group had opening pressure above 25 cm H2O on lumbar puncture, with normal fluid composition and documented clinical improvement on follow up examinations.
Healthy volunteers had best-corrected visual acuity of 0.2 logMAR or better, refractive error −3.0 to +3.0 diopters, and no changes on visual field testing.
Participants from all groups had normal IOP, no other eye conditions or systemic disease, and no previous intraocular or refractive surgery.
The study was approved by the local ethics committee and adhered to the tenets of the Declaration of Helsinki. Each participant or parents/guardians of participants gave informed consent.